Business Context and Reporting Period
This Form 6-K filing by GSK plc, dated July 21, 2025, reports a transaction in the company's own shares. The filing covers a share repurchase executed on July 18, 2025, as part of an existing buyback programme.
Key Financial Metrics
The filing details a specific share repurchase transaction rather than comprehensive financial statements. Key metrics related to this transaction include:
- Shares Purchased: 505,771 ordinary shares.
- Price Range: Lowest price paid was 1,319.00p; highest price paid was 1,360.50p.
- Average Price: Volume-weighted average price paid was 1,344.42p.
- Treasury Holdings: Following this purchase, GSK holds 232,817,467 ordinary shares in treasury.
- Shares in Issue: 4,082,566,813 ordinary shares (excluding treasury shares).
- Voting Rights: Treasury shares represent 5.70% of total voting rights.
The filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes
Since the commencement of the current buyback agreement on June 4, 2025, the company has purchased an aggregate of 14,683,084 ordinary shares. The most recent transaction on July 18, 2025, increased the total treasury share count to 232,817,467.
Guidance, Outlook, and Risks
The filing confirms the repurchase was effected pursuant to a non-discretionary agreement with Merrill Lynch International. GSK includes a standard cautionary statement regarding forward-looking statements, noting that actual results may differ materially from projections due to risks described in the 2024 Annual Report on Form 20-F and Q1 2025 Results. No specific guidance or outlook regarding future financial performance is provided in this document.
Investor Verification Checklist
- Verify the total number of shares held in treasury (232,817,467) against the company's latest capital structure disclosures.
- Confirm the 5.70% voting rights attribution for treasury shares under FCA Disclosure Guidance and Transparency Rules.
- Review the detailed trade information available via the provided London Stock Exchange link for individual transaction execution details.
- Check the remaining capacity under the buyback programme announced on June 4, 2025.